CIK 0001367083 · Non-accelerated filer<br>Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680423298
- Phone
- 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −20,000 | 147,733 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −50,000 | 97,733 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −30,000 | 67,733 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −67,733 | 0 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −5,271 | 203,800 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −5,357 | 198,443 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −357 | 198,086 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −5,000 | 193,086 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −1,785 | 191,301 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −4,285 | 187,016 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −5,351 | 181,665 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −26,020 | 155,645 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −7,912 | 147,733 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −50,000 | 97,733 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −30,000 | 67,733 | ||
| 2019-01-14 | Miller Robert E Former CFO | Other disposition · Stock option (right to buy) | −67,733 | 0 | ||
| 2019-01-10 | Sandford Frederick J CEO and Interim CFO | Grant or award · Stock option (right to buy) | +400,000 | 400,000 | ||
| 2019-01-10 | Sandford Frederick J CEO and Interim CFO | Grant or award · Stock option (right to buy) | +50,000 | 450,000 | ||
| 2018-07-20 | Schutz James J Chief Executive Officer | Grant or award · Stock option (right to buy) | +67,733 | 193,358 | ||
| 2018-07-20 | Miller Robert E Chief Financial Officer | Grant or award · Stock option (right to buy) | +67,733 | 209,071 |
Page 4 of 7 · 127 trades